Table 4 Cross-reactivity analysis of ADA
From: B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
Patient ID | Age | Anti-ADL (µg/ml) | Control ID | Age | Anti-ADL (µg/ml) |
|---|---|---|---|---|---|
438 | 29 | <1.25 | P* | 48 | <1.25 |
452 | 30 | <1.25 | F10 | 20 | <1.25 |
485 | 64 | <1.25 | F22 | 25 | <1.25 |
522 | 42 | ≤1.25 | F28 | 22 | <1.25 |
587 | 41 | <1.25 | F31 | 45 | <1.25 |
609 | 30 | <1.25 | F32 | 59 | <1.25 |
623 | 57 | <1.25 | F33 | 25 | <1.25 |
626 | 57 | <1.25 | F38 | 53 | <1.25 |
638 | 32 | <1.25 | F41 | 19 | <1.25 |
639 | 33 | <1.25 | F42 | 32 | <1.25 |
648 | 4 | <1.25 | F43 | 31 | <1.25 |
652 | 31 | <1.25 | F44 | 44 | <1.25 |
660 | 26 | <1.25 | F45 | 36 | <1.25 |
681 | ? | <1.25 | F46 | 35 | <1.25 |
694 | 13 | <1.25 | F47 | 33 | <1.25 |
695 | 37 | <1.25 | |||
719 | 16 | <1.25 | |||
721 | ? | <1.25 | |||
722 | 42 | <1.25 | |||
724 | 80 | <1.25 |